GO:0035795 negative regulation of mitochondrial membrane permeability: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0035795 (negative regulation of mitochondrial membrane permeability) describes any process that decreases the passage or uptake of molecules across the mitochondrial membrane, thereby preserving mitochondrial integrity.
• The mitochondrial permeability transition pore (mPTP) is the central effector of mitochondrial membrane permeability, and its opening is inhibited by negative regulators such as the ATP synthase.
• The ATP synthase acts as a negative regulator of the mPTP, and its structural components are functionally distinct from the high-conductance pore state.
• SPG7 has been predicted to regulate mPTP and mitochondrial flickering, linking negative regulation of permeability to chronic obstructive pulmonary disease (COPD).
• Mitophagy and mitochondrial network signaling influence oxidative stress and apoptosis during myoblast differentiation, processes that depend on controlled membrane permeability.
• Dysregulation of mitochondrial membrane permeability is implicated in autism spectrum disorder, chronic intestinal inflammation, and primary open angle glaucoma.
Description
Mitochondria are double-membrane organelles that carry out oxidative phosphorylation and regulate cell death. The inner mitochondrial membrane is normally impermeable to most solutes, and this barrier is essential for maintaining the proton gradient that drives ATP synthesis. The term GO:0035795, negative regulation of mitochondrial membrane permeability, refers to any process that decreases the frequency, rate, or extent of molecular passage or uptake across the mitochondrial membrane. This regulatory process is critical because uncontrolled opening of the mitochondrial permeability transition pore (mPTP) dissipates the membrane potential, causes osmotic swelling, and triggers cell death. Research on negative regulation of mitochondrial membrane permeability has revealed that the ATP synthase functions as a negative regulator of the mPTP, meaning that its presence or activity reduces pore opening. This finding has reshaped the understanding of mPTP regulation, distinguishing the ATP synthase's catalytic role from its structural contribution to the high-conductance state. Additional regulators, such as SPG7, have been predicted to modulate mPTP and mitochondrial flickering in disease contexts like COPD. Understanding GO:0035795 is important for researchers studying cell death, metabolic stress, and organelle quality control. For example, mitophagy regulates mitochondrial network signaling, oxidative stress, and apoptosis during myoblast differentiation, processes that rely on controlled membrane permeability. Moreover, altered mitochondrial permeability is associated with autism spectrum disorder, chronic intestinal inflammation, and primary open angle glaucoma, making this term a focal point for disease mechanism studies.
negative regulation of mitochondrial membrane permeability At A Glance
| GO ID | GO:0035795 |
|---|---|
| GO term | negative regulation of mitochondrial membrane permeability |
| Ontology | biological_process |
| Synonym | mitochondrial membrane impermeability; mitochondrial membrane impermeabilization; negative regulation of transport across mitochondrial membrane |
| Major function | Decreases the passage or uptake of molecules across the mitochondrial membrane, preserving mitochondrial integrity and function. |
| Key effector | Mitochondrial permeability transition pore (mPTP) |
| Key negative regulator | ATP synthase (complex V) |
| Associated disease contexts | Autism spectrum disorder, chronic intestinal inflammation, primary open angle glaucoma, COPD |
| Research relevance | Target for studies on cell death, oxidative stress, mitophagy, and metabolic regulation. |
What Is GO:0035795?
GO:0035795 (negative regulation of mitochondrial membrane permeability) is a biological process defined as any process that decreases the frequency, rate, or extent of the passage or uptake of molecules by the mitochondrial membrane. In other words, it encompasses molecular mechanisms that make the mitochondrial membrane less permeable to ions, metabolites, or other solutes. This includes inhibition of pore opening, stabilization of membrane structure, and regulation of transport proteins. The term is synonymous with mitochondrial membrane impermeability, mitochondrial membrane impermeabilization, and negative regulation of transport across mitochondrial membrane.
Why Is negative regulation of mitochondrial membrane permeability Important in Cell Biology?
Negative regulation of mitochondrial membrane permeability is essential for maintaining the mitochondrial electrochemical gradient, ATP production, and cell survival. When this regulation fails, uncontrolled opening of the mPTP leads to mitochondrial swelling, rupture of the outer membrane, and release of pro-apoptotic factors, contributing to diseases ranging from neurodegeneration to inflammatory disorders. Thus, understanding the molecular players that negatively regulate permeability provides mechanistic insight into cell death pathways and identifies potential therapeutic targets.
• Preserves the proton gradient across the inner mitochondrial membrane, which is required for ATP synthesis.
• Prevents osmotic swelling and rupture of mitochondria during stress.
• Inhibits the mitochondrial permeability transition pore (mPTP), a key executor of necrotic and apoptotic cell death.
• Modulates oxidative stress and apoptosis during myoblast differentiation via mitophagy.
• Is implicated in autism spectrum disorder through multifaceted mitochondrial dysfunction.
• Plays a role in chronic intestinal inflammation driven by hypermetabolic CD4+ T cells.
• May contribute to primary open angle glaucoma pathogenesis as a candidate gene pathway.
• SPG7-mediated regulation of mPTP and mitochondrial flickering is predicted to be relevant in COPD.
• Provides a mechanistic framework for understanding how cells adapt to metabolic stress.
• Offers potential targets for therapeutic intervention in diseases characterized by mitochondrial permeability dysregulation.
What Happens During negative regulation of mitochondrial membrane permeability?
Inhibition of mPTP opening
In simple terms: The mitochondrial permeability transition pore is a channel that, when open, makes the inner membrane leaky; negative regulation keeps this channel closed.
The mitochondrial permeability transition pore (mPTP) is a high-conductance channel whose opening increases inner membrane permeability to solutes and water. Negative regulation of mitochondrial membrane permeability involves processes that decrease the frequency or extent of mPTP opening. The ATP synthase has been identified as a negative regulator of the mPTP, meaning that its presence or activity reduces pore opening. This regulation is critical because sustained mPTP opening leads to mitochondrial swelling, loss of membrane potential, and cell death.
Stabilization of the inner membrane barrier
In simple terms: The inner mitochondrial membrane is normally tight; negative regulation reinforces this barrier so that ions and small molecules cannot leak through.
The inner mitochondrial membrane is intrinsically impermeable to most solutes, and this property is maintained by lipid composition and protein complexes. Negative regulation of permeability includes mechanisms that stabilize this barrier, preventing non-specific leakage. For example, the ATP synthase complex contributes to membrane impermeability under normal conditions, and its structural integrity is required to prevent aberrant pore formation. Disruption of this stabilization leads to increased permeability and mitochondrial dysfunction.
Regulation by mitophagy and mitochondrial network signaling
In simple terms: Mitophagy, the selective removal of damaged mitochondria, helps keep the remaining mitochondrial population healthy and less permeable.
Mitophagy regulates mitochondrial network signaling, oxidative stress, and apoptosis during myoblast differentiation. By removing damaged mitochondria that may have increased membrane permeability, mitophagy indirectly supports negative regulation of mitochondrial membrane permeability. This quality-control pathway ensures that only mitochondria with intact membrane barriers contribute to the cellular pool, thereby maintaining metabolic homeostasis.
Modulation by SPG7 and mitochondrial flickering
In simple terms: SPG7 is a protein that can influence rapid, reversible changes in mitochondrial membrane permeability, sometimes called flickering.
SPG7 has been predicted to regulate the mPTP and mitochondrial flickering, a phenomenon of transient pore openings. This bioinformatics-based prediction suggests that SPG7 may act as a negative regulator of mitochondrial membrane permeability in the context of COPD. Mitochondrial flickering represents brief, reversible increases in permeability that can be modulated by regulatory proteins, and SPG7 is proposed to play a role in this process.
Integration with cellular metabolic state
In simple terms: The cell's metabolic status influences how tightly the mitochondrial membrane is sealed, linking energy demand to permeability control.
Negative regulation of mitochondrial membrane permeability is integrated with cellular metabolic state. For instance, interleukin 21 drives a hypermetabolic state in CD4+ T cells associated with chronic intestinal inflammation, and this metabolic reprogramming may involve changes in mitochondrial membrane permeability. Similarly, in autism spectrum disorder, multifaceted mitochondrial dysfunction includes altered permeability regulation. These examples illustrate how negative regulation of permeability is coupled to broader metabolic and inflammatory signaling.
Key Genes Involved in GO:0035795 negative regulation of mitochondrial membrane permeability
The following genes and proteins have been experimentally or computationally linked to negative regulation of mitochondrial membrane permeability, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ATP5F1A | Component of ATP synthase, which acts as a negative regulator of mPTP | Studied for its role in inhibiting mPTP opening |
| ATP5F1B | Component of ATP synthase, negative regulator of mPTP | Target for understanding mPTP regulation |
| SPG7 | Predicted regulator of mPTP and mitochondrial flickering | Bioinformatics-based prediction in COPD |
| PINK1 | Mitophagy regulator, supports mitochondrial quality control | Linked to mitophagy and permeability regulation |
| PRKN | E3 ubiquitin ligase in mitophagy, removes damaged mitochondria | Studied in myoblast differentiation and apoptosis |
| VDAC1 | Outer membrane channel, modulates metabolite flux | Potential indirect regulator of permeability |
| ANT1 (SLC25A4) | Inner membrane ADP/ATP carrier, component of mPTP | Historical mPTP component, studied with patch-clamp |
| CYPD (PPIF) | Peptidyl-prolyl isomerase, mPTP modulator | Classic mPTP regulator, used in whole-mitoplast patch-clamp |
| IL21 | Cytokine driving hypermetabolic state in CD4+ T cells | Linked to chronic intestinal inflammation |
| IL21R | Receptor for IL-21, mediates signaling | Studied in T-cell pathogenicity |
| MYOD1 | Myogenic transcription factor | Mitophagy during myoblast differentiation |
| MYOG | Myogenin, differentiation marker | Mitophagy and apoptosis in myoblasts |
| OPA1 | Inner membrane fusion protein, maintains cristae structure | Indirectly affects membrane permeability |
| MFN1 | Outer membrane fusion protein | Mitochondrial network signaling |
| MFN2 | Outer membrane fusion protein | Mitochondrial network signaling |
| DNM1L (DRP1) | Fission protein, regulates mitochondrial morphology | Affects permeability and apoptosis |
| BECN1 | Autophagy regulator, involved in mitophagy | Quality control of mitochondria |
| MAP1LC3B | Autophagosome marker, used in mitophagy assays | Mitophagy and permeability studies |
How Is negative regulation of mitochondrial membrane permeability Regulated?
Negative regulation of mitochondrial membrane permeability is itself regulated at multiple levels. The ATP synthase acts as a negative regulator of the mPTP, and its activity can be modulated by metabolic cues. SPG7 is predicted to regulate mPTP and mitochondrial flickering, suggesting a protein-level control mechanism. Mitophagy, regulated by PINK1, PRKN, and autophagy proteins, removes damaged mitochondria and thereby maintains a population with low permeability. In inflammatory contexts, interleukin 21 drives a hypermetabolic state that may alter mitochondrial permeability regulation. These layers of regulation ensure that mitochondrial membrane permeability is tightly coupled to cellular energy status and stress responses.
negative regulation of mitochondrial membrane permeability and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ATP5F1A | mPTP regulation, cell death | Knockout or point-mutation cell lines to test mPTP opening |
| SPG7 | COPD, mitochondrial flickering | Overexpression or knockout in lung epithelial cells |
| IL21 | Chronic intestinal inflammation | Knockout mice or T-cell lines to assess metabolic state |
| PINK1 | Mitophagy, myoblast differentiation | Knockout myoblasts to measure permeability and apoptosis |
| PRKN | Mitophagy, oxidative stress | Knockout or overexpression in myoblasts |
Autism spectrum disorder
Mitochondria play a multifaceted role in autism spectrum disorder, and dysregulation of mitochondrial membrane permeability is one component of mitochondrial dysfunction in this condition. Negative regulation of permeability is important for neuronal survival, and its impairment may contribute to the pathophysiology of autism spectrum disorder.
Chronic intestinal inflammation
Interleukin 21 drives a hypermetabolic state and CD4+ T-cell-associated pathogenicity in chronic intestinal inflammation. This hypermetabolic state likely involves changes in mitochondrial membrane permeability, and negative regulation of permeability may influence T-cell survival and inflammatory potential.
Primary open angle glaucoma
Screening of candidate genes for primary open angle glaucoma has identified mitochondrial-related pathways, and negative regulation of mitochondrial membrane permeability may be relevant to retinal ganglion cell death in this disease. Although direct evidence is limited, the mitochondrial permeability transition is a known contributor to neuronal apoptosis.
Chronic obstructive pulmonary disease (COPD)
SPG7-mediated regulation of mPTP and mitochondrial flickering has been predicted as a mechanistic framework in COPD. This suggests that negative regulation of mitochondrial membrane permeability may be protective against COPD pathogenesis, and its dysregulation could contribute to disease progression.
From negative regulation of mitochondrial membrane permeability-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does ATP synthase negatively regulate mPTP? | ATP5F1A knockout or point-mutation cells |
| How does SPG7 affect mitochondrial flickering? | SPG7 overexpression and knockout in COPD models |
| What is the role of mitophagy in permeability regulation? | PINK1 or PRKN knockout myoblasts |
| How does IL-21 alter mitochondrial permeability? | IL21 or IL21R knockout T cells |
| Is mitochondrial permeability altered in autism? | Patient-derived or model cell lines with mitochondrial dysfunction |
| Can we measure mPTP directly? | Whole-mitoplast patch-clamp technique |
How to Study the negative regulation of mitochondrial membrane permeability Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Whole-mitoplast patch-clamp | mPTP currents and pore properties | Direct measurement of permeability regulation |
| Mito-Keima imaging | Mitophagy flux | Quality control of mitochondria |
| Seahorse extracellular flux | Oxygen consumption and glycolysis | Metabolic state in T cells |
| Western blot | Protein levels of PINK1, PRKN, LC3B | Mitophagy and apoptosis |
| Fluorescence microscopy | Mitochondrial morphology and membrane potential | Network signaling and permeability |
| Bioinformatics pathway analysis | Gene enrichment and mechanistic prediction | SPG7-mPTP framework in COPD |
| Cytokine profiling | IL-21 and inflammatory markers | Chronic intestinal inflammation |
| Genotyping/sequencing | Candidate gene variants | Primary open angle glaucoma screening |
Whole-mitoplast patch-clamp
The whole-mitoplast patch-clamp technique allows direct investigation of the properties of the mitochondrial permeability transition pore. This method measures currents through the mPTP in isolated mitoplasts, providing quantitative data on pore opening and regulation. It is a gold-standard approach for studying negative regulation of mitochondrial membrane permeability at the single-channel level.
Mitophagy and mitochondrial network assays
Mitophagy regulates mitochondrial network signaling, oxidative stress, and apoptosis during myoblast differentiation. Researchers use fluorescence microscopy, mito-Keima, and Western blotting for LC3B and PINK1 to assess mitophagy and its impact on membrane permeability. These assays help determine how quality control pathways contribute to negative regulation of permeability.
Bioinformatics-based prediction
Bioinformatics approaches can predict mechanistic frameworks, such as the SPG7-mediated regulation of mPTP and mitochondrial flickering in COPD. These methods integrate gene expression, pathway enrichment, and structural modeling to generate hypotheses about negative regulation of mitochondrial membrane permeability.
Metabolic and inflammatory profiling
Interleukin 21 drives a hypermetabolic state in CD4+ T cells, which can be studied using Seahorse extracellular flux analysis, glucose uptake assays, and cytokine profiling. These methods link metabolic reprogramming to changes in mitochondrial membrane permeability regulation.
How CRISPR Can Be Used to Study GO:0035795 negative regulation of mitochondrial membrane permeability
Knockout
CRISPR knockout of genes such as ATP5F1A, SPG7, or PINK1 can be used to test their role in negative regulation of mitochondrial membrane permeability. Knockout cells can be challenged with inducers of mPTP opening and assessed for mitochondrial swelling, membrane potential, and cell death. This approach directly tests whether a gene is required for maintaining membrane impermeability.
Point Mutation
Point mutations can be introduced into genes like ATP5F1A or SPG7 to dissect specific residues involved in mPTP regulation. For example, mutations that alter ATP synthase activity can reveal whether its negative regulatory function is separable from its catalytic role. Point-mutation models help distinguish between structural and functional contributions to permeability regulation.
Knock-in
Knock-in of tagged versions of proteins such as SPG7 or ATP5F1A allows visualization and immunoprecipitation of the endogenous proteins. Tagged knock-in models can be used to study protein localization, interactions, and post-translational modifications in the context of mitochondrial membrane permeability. This approach preserves endogenous regulation while enabling biochemical analysis.
Overexpression
Overexpression of negative regulators like ATP synthase subunits or SPG7 can test whether increased levels enhance membrane impermeability and protect against mPTP opening. Overexpression models are useful for gain-of-function studies and for identifying protective effects against stress-induced permeability. They complement knockout approaches to establish causality.
How EDITGENE Supports negative regulation of mitochondrial membrane permeability Research
Researchers studying negative regulation of mitochondrial membrane permeability-related genes often need to determine whether a candidate gene is causally involved in maintaining membrane impermeability or modulating the mPTP. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such investigations, from knockout to overexpression and library screening.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of mitochondrial membrane permeability research.
Frequently Asked Questions About negative regulation of mitochondrial membrane permeability
What is GO:0035795?
GO:0035795 is the Gene Ontology term for negative regulation of mitochondrial membrane permeability, defined as any process that decreases the frequency, rate, or extent of molecular passage or uptake across the mitochondrial membrane.
What genes are involved in negative regulation of mitochondrial membrane permeability?
Key genes include ATP5F1A and ATP5F1B (ATP synthase subunits), SPG7, PINK1, PRKN, and IL21, based on experimental and bioinformatics studies.
How does the ATP synthase negatively regulate the mPTP?
The ATP synthase acts as a negative regulator of the mitochondrial permeability transition pore, meaning its presence or activity reduces pore opening.
What is the mitochondrial permeability transition pore?
The mPTP is a high-conductance channel in the inner mitochondrial membrane whose opening increases permeability to solutes and can trigger cell death.
How is mitochondrial membrane permeability measured?
Whole-mitoplast patch-clamp is a direct technique to investigate mPTP properties and measure permeability at the single-channel level.
What diseases are linked to mitochondrial membrane permeability?
Diseases include autism spectrum disorder, chronic intestinal inflammation, primary open angle glaucoma, and COPD.
What is the role of mitophagy in permeability regulation?
Mitophagy removes damaged mitochondria and regulates oxidative stress and apoptosis, indirectly supporting negative regulation of mitochondrial membrane permeability.
How does SPG7 regulate mitochondrial permeability?
SPG7 is predicted to regulate mPTP and mitochondrial flickering, particularly in COPD, based on bioinformatics analysis.
Can CRISPR be used to study negative regulation of mitochondrial membrane permeability?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models can test the causal role of genes like ATP5F1A, SPG7, and PINK1 in permeability regulation.
What is mitochondrial flickering?
Mitochondrial flickering refers to transient, reversible openings of the mPTP that can be modulated by regulatory proteins such as SPG7.
Conclusion
GO:0035795 (negative regulation of mitochondrial membrane permeability) is a critical biological process that preserves mitochondrial integrity by limiting molecular passage across the mitochondrial membrane. The ATP synthase, SPG7, and mitophagy-related proteins are key players in this regulation, and their dysfunction is linked to autism spectrum disorder, chronic intestinal inflammation, primary open angle glaucoma, and COPD. Understanding these mechanisms offers opportunities for therapeutic intervention. Researchers can leverage CRISPR-based models, including knockout, point mutation, knock-in, and overexpression, to dissect the causal roles of specific genes in this process. EDITGENE provides end-to-end services to accelerate such studies and uncover new regulators of mitochondrial membrane permeability.
References
- 1. Khaliulin I et al.. 2025. The multifaceted role of mitochondria in autism spectrum disorder.. Mol Psychiatry 30(2):629-650 PMID: 39223276
- 2. Baechler BL et al.. 2019. Mitophagy regulates mitochondrial network signaling, oxidative stress, and apoptosis during myoblast differentiation.. Autophagy 15(9):1606-1619 PMID: 30859901
- 3. Pekson R et al.. 2023. The mitochondrial ATP synthase is a negative regulator of the mitochondrial permeability transition pore.. Proc Natl Acad Sci U S A 120(51):e2303713120 PMID: 38091291
- 4. Neginskaya MA et al.. 2023. Investigation of Properties of the Mitochondrial Permeability Transition Pore Using Whole-Mitoplast Patch-Clamp Technique.. DNA Cell Biol 42(8):481-487 PMID: 37311169
- 5. Nesci S. 2024. ATP synthase as a negative regulator versus a functional-structural component of the high conductance state of mitochondrial permeability transition pore.. J Biochem Mol Toxicol 38(9):e23821 PMID: 39194336
- 6. Xu A et al.. 2026. SPG7-Mediated Regulation of mPTP and Mitochondrial Flickering in COPD: A Bioinformatics-Based Prediction of Mechanistic Framework.. Int J Chron Obstruct Pulmon Dis 21:597903 PMID: 42404999
- 7. Bamidele AO et al.. 2024. Interleukin 21 Drives a Hypermetabolic State and CD4(+) T-Cell-Associated Pathogenicity in Chronic Intestinal Inflammation.. Gastroenterology 166(5):826-841.e19 PMID: 38266738
- 8. Liu T et al.. 2012. Screening of candidate genes for primary open angle glaucoma.. Mol Vis 18:2119-26 PMID: 22876139
